Predicting risk of secondary progression in multiple sclerosis: A nomogram

Progressive multiple sclerosis: prospects for disease therapy, repair, and restoration of function

(2017) Daniel Ontaneda et al.   LANCET

Long-term evolution of multiple sclerosis disability in the treatment era

(2016) et al.   ANNALS OF NEUROLOGY

Defining secondary progressive multiple sclerosis

(2016) Johannes Lorscheider et al.   BRAIN

Clinical course of multiple sclerosis: A nationwide cohort study

(2016) Ali Manouchehrinia et al.   Multiple Sclerosis Journal

Importance of early treatment initiation in the clinical course of multiple sclerosis

(2016) Andrius Kavaliunas et al.   Multiple Sclerosis Journal

Clinical course of multiple sclerosis: A nationwide cohort study

(2016) Ali Manouchehrinia et al.   Multiple Sclerosis Journal

Importance of early treatment initiation in the clinical course of multiple sclerosis

(2016) Andrius Kavaliunas et al.   Multiple Sclerosis Journal

The Swedish MS registry - clinical support tool and scientific resource

(2015) J. Hillert et al.   ACTA NEUROLOGICA SCANDINAVICA

Beta-interferon exposure and onset of secondary progressive multiple sclerosis

(2015) T. Zhang et al.   EUROPEAN JOURNAL OF NEUROLOGY

A much-needed focus on progression in multiple sclerosis

(2015) Alan J Thompson   LANCET NEUROLOGY

Development and validation of nomograms to provide individualised predictions of seizure outcomes after epilepsy surgery: a retrospective analysis

(2015) Lara Jehi et al.   LANCET NEUROLOGY

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial

(2014) Peter A Calabresi et al.   LANCET NEUROLOGY

Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study

(2013) Ali Manouchehrinia et al.   BRAIN

Brain atrophy and lesion load predict long term disability in multiple sclerosis

(2013) Veronica Popescu et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Neurofilaments as biomarkers in multiple sclerosis

(2012) Charlotte E Teunissen et al.   Multiple Sclerosis Journal

External validation of nomogram for the prediction of recurrence after curative resection in early gastric cancer

(2011) J. H. Kim et al.   ANNALS OF ONCOLOGY

The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability

(2010) Antonio Scalfari et al.   BRAIN

The natural history of secondary progressive multiple sclerosis

(2010) M. Koch et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Emerging effects of comorbidities on multiple sclerosis

(2010) Ruth Ann Marrie et al.   LANCET NEUROLOGY

New perspectives in the natural history of multiple sclerosis

(2010) H. Tremlett et al.   NEUROLOGY

A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis

(2010) Ludwig Kappos et al.   NEW ENGLAND JOURNAL OF MEDICINE

Review: Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode

(2009) DS Goodin et al.   Multiple Sclerosis Journal

Impact of multiple sclerosis relapses on progression diminishes with time

(2009) H. Tremlett et al.   NEUROLOGY

Natural history of multiple sclerosis in a population-based cohort

(2008) M. Debouverie et al.   EUROPEAN JOURNAL OF NEUROLOGY

Factors associated with the risk of secondary progression in multiple sclerosis

(2008) M Koch et al.   Multiple Sclerosis Journal

Natural history of secondary-progressive multiple sclerosis

(2008) Helen Tremlett et al.   Multiple Sclerosis Journal

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3

(2007) Thierry Gorlia et al.   LANCET ONCOLOGY